The 272 patients with advanced or metastatic SCC were randomized to either nivolumab or docetaxel after having progressed on prior platinum-based chemotherapy. Cytotoxic chemotherapy · EGFR targeted therapy

Treatment options for squamous cell lung cancer · Surgery · Radiation therapy · Chemotherapy · Angiogenesis inhibitors · Immunotherapy. Immunotherapy is a type ...

The 272 patients with advanced or metastatic SCC were randomized to either nivolumab or docetaxel after having progressed on prior platinum-based chemotherapy.

The initial treatment for metastatic squamous cell non-small cell lung cancer (NSCLC) consists of platinum-based combination chemotherapy.

17 мая 2019 г. · Pembrolizumab monotherapy (PD-L1 TPS ≥ 50%) and carboplatin plus taxane plus pembrolizumab combinatorial therapy are new first-line standards of care.

Docetaxel, gemcitabine and platinum-based chemotherapy may be options for some patients, but overall, there are very few options for patients requiring second- ...

22 сент. 2020 г. · For patients treated with chemotherapy in the first-line, options include nivolumab or atezolizumab for any level of PD-L1 expression, ...

25 сент. 2018 г. · Standard first-line therapy for metastatic, squamous non–small-cell lung cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for ...

11 окт. 2024 г. · Chemotherapy may be used alone, in conjunction with radiation therapy, or before or after surgery for lung cancer. It may also be combined with ...

31 окт. 2023 г. · Neoadjuvant chemotherapy plus immunotherapy in the treatment of potentially resectable stage III lung squamous cell carcinoma (LSCC) is feasible and safe.